TCT 2006: New definitions of thrombosis give reprieve to first-gen DESs (drug-eluting stents)
This article was originally published in Clinica
New data and new definitions suggest that patients implanted with the first-generation drug-eluting stents (DESs) Cypher and Taxus may be at less risk of late blood clots than previously thought.
You may also be interested in...
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.